Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Journal of Clinical Laboratory Analysis|September 26, 2024
Diagnostic Performance of CLEIA Versus FEIA for KL-6 Peripheral and Alveolar Concentrations in Fibrotic Interstitial Lung Diseases: A Multicentre StudyMiriana d'Alessandro, Sara Gangi, Irene Paggi, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 23, 2020
Serum Amyloid A in lung transplantationLucia Vietri, Elena Bargagli, David Bennett, et al.
Medicine|July 3, 2019
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do?Elena Bargagli, Maria Antonietta Mazzei, Martina Orlandi, et al.
Therapeutic Advances in Respiratory Disease|February 19, 2020
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of SienaLucia Vietri, Paolo Cameli, Marco Perruzza, et al.
BMC Pulmonary Medicine|March 20, 2026
When BAL meets CT scan: enhancing noninvasive diagnosis of acute cellular rejection after lung transplantationElena Pordon, Marco Guerrieri, Felice Perillo, et al.
Respiratory Research|January 8, 2020
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosisDavid Bennett, Paolo Cameli, Nicola Lanzarone, et al.
Internal and Emergency Medicine|February 21, 2020
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological featuresNicola Lanzarone, Francesco Gentili, Valerio Alonzi, et al.
Respiratory Research|January 31, 2020
Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosisDavid Bennett, Paolo Cameli, Nicola Lanzarone, et al.
Journal of Medical Virology|May 30, 2020
Serum KL-6 concentrations as a novel biomarker of severe COVID-19Miriana d'Alessandro, Paolo Cameli, Rosa Metella Refini, et al.
Pageof 13